Trial Profile
The effect of Pregabalin on Pain progressing in Painful Diabetic Neuropathy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2015
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 17 Aug 2011 primary and secondary endpoints unclear.
- 15 Aug 2011 New trial record